Developed the first genomic test for personalized HER2+ breast cancer treatments
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Autoimmune diseases are caused by the body attacking itself. Around 20% of the population develops an autoimmune disease, and about one hundred diffe1
Dr. Francisco Carmona, head of the Gynaecology Service, has just been appointed president of the Society of Endometriosis and Uterine Disorders. We s1
The Hospital Clínic de Barcelona has incorporated a new robot to improve the detection of skin cancer. It is the Vectra WB360, a device that combines1
Decisions made during delivery can prevent Pelvic Floor Disorders (PFD), for example avoiding assisted birth (forceps), protecting the perineum as th1
Ten IDIBAPS groups are looking for candidates to apply for one of the 35 pre-doctoral scholarships offered by the INPhINIT Incoming program of the La1
The COVID-19 pandemic and lockdown have increased anxiety and depression in many people, but a study has found that eating a balanced diet can help p1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
The Omicron variant that appeared in South Africa in November 2021 displaced the Delta variant in 3-4 weeks in over 100 countries and now represents1
Interview with Dr. Alba Roca, psychiatrist in the Perinatal Mental Health Unit. We speak to her about the invisibilization of different mental disord1